ATRIAL FIBRILLATION ASSOCIATED WITH ARTERIAL HYPERTENSION
- Авторлар: Volkov V.E.1, Volkov VY.1
-
Мекемелер:
- Шығарылым: № 14 (2011)
- Беттер: 20-23
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278967
- ID: 278967
Дәйексөз келтіру
Толық мәтін
Аннотация
Atrial fibrillation (AF) and arterial hypertension (AH) are two most common, often combined pathologies of the cardiovascular system. The incidence of these diseases increases with age; they lead to numerous complications and high mortality. Although the relationship between these pathologies is not fully investigated, the treatment of AH is not a new approach to the correction of AF. Aggressive treatment of AH can prevent the structural changes of the myocardium, reduce the incidence of thromboembolic complications, and slow or prevent the occurrence of AF in patients with this type of atrial tachyarrhythmias. Specific drug therapy plays an important role in primary and secondary prevention of AF and its complications.
Негізгі сөздер
Әдебиет тізімі
- Драпкина О.М., Костюкевич М.В. Артериальная гипертензия: от фибрилляции предсердий и инсульта до метаболического синдрома // Справочник поликлинического врача 2010. № 8. С. 18-21.
- Романов Е.Е., Кириченко А.А. Антигипертензивная терапия у больных пароксизмальной формой фибрилляции предсердий: имеет ли значение выбор препарата? // Фарматека 2009. № 11(183). С. 69-74.
- Шварц Ю.Г., Салеева Е.В., Кузнецова Л.И. Лозартан в лечении больных пароксизмальной мерцательной аритмией, сочетающейся с артериальной гипертонией // Вестник аритмологии 1999. № 8. С. 56-9.
- Allessie MA, Boyden PA, Camm AJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001;6:769-77.
- Ciaroni S, Cuenoud L, Bloch A. Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension. Am Heart J 2000;139:814-9.
- Dixen U, Ravn L, Soeby-Rasmussen C, et al. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation. Cardiology 2007;108:35-9.
- Fogari R, Zoppi A, Mugellini A, et al Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus. J Cardiovasc Pharmacol 2008;51:217-22.
- Healey JS, Connolly SJ. Atrial Fibrillation: Hypertension as a Causative Agent, Risk Factor for Complications, and Potential Therapeutic Target. Am J Cardiol 2003;91:9G-14G.
- Heckbert SR. Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population. Am J Hypertens 2009;22:538-44.
- Krishnamoorty S. Lip GYH hypertension, stroke and the impact of atrial fibrillation. Expert rev Cardiovasc Ther 2008;6:1287-9.
- Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96:2455-61.
- Schaer BA, Schneider C, Jick SS, et al. Effect of Antihypertensive Drugs on Risk for Atrial Fibrillation. An Int Med 2010;152:78-4
- Schimieder R, kjeldsen SE, Julius S, et al. Reduced incidence of new onset strial fibrillation with angiotensin II receptor blockade, the VALUE trial. J Hypertens 2008;26:403-11.
- Solun B, Marcoviciu D, Dicker D. Does treatment of hypertension decrease the incidence of atrial fibrillation and cardioembolic stroke? Eur J Int Med 2009;20:125-31.
- Tsang TS, Barnes ME, Bailey KR, et.al. left atrial volume, important risk marker of incident atrial fibrillation in 1655 older men and women. Clin Proc 2001;76:467-75.
- Vaziri SM, Larson MG, Lauer MS, et al. Influence of blood pressure on left atrial size. The Framingham Heart study. Hypertension 1995;25:1155-60.
- Wachtell K, et al. Cardiovascular Morbidity and Mortality in Hypertensive Patients With a History of Atrial Fibrillation.The Losartan Intervention for End Point Reduction in Hypertension (LIFE) Study. J Am Coll Cardiol Mar 2005;45:705-11.
- Wachtell K, et al. Angiotensin II Receptor Blockade Reduces New-Onset Atrial Fibrillation and Subsequent Stroke Compared to Atenolol. The Losartan Intervention for End Point Reduction in Hypertension (LIFE) Study. J Am Coll Cardiol Mar 2005;45:712-9.
- Yamashita T J-RHYTHM II Study: A Randomized Comparison Of Angiotensin Receptor Blocker Versus Ca Antagonist For Paroxysmal Atrial Fibrillation With Hypertension. Circ J 2006;70:1318-21.
Қосымша файлдар
